Toxic epidermal necrolysis due to administration of celecoxib (Celebrex)

Southern Medical Journal

Volumn 95, Issue 10, 2002, Pages 1213-1214

  Friedman, Bruce ^a   Orlet, Hermann K ^a   Still, Joseph M ^a   Law, Edward ^a  

^a Physicians' Multispecialty Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH DERIVATIVE; BISMUTH TRIBROMOPHENATEIN; CELECOXIB; PETROLATUM; PSEUDOMONIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARPAL TUNNEL SYNDROME; CASE REPORT; CREAM; ERYTHEMA; EXFOLIATIVE DERMATITIS; FEMALE; HUMAN; TOXIC EPIDERMAL NECROLYSIS; WOUND DRESSING; WOUND HEALING;

EID: 0036775932     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200210000-00022     Document Type: Article

References (7)

1. Chan HL, Stern RS, Arndt KA, et al: The incidence of erythema multiforme, Stevens-Johnson's syndrome, and toxic epidermal necrolysis: A population based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126:43-47
2. Prendiville JS, Hebert AA, Greenwald MJ, et al: Management of Stevens-Johnson's syndrome and toxic epidermal necrolysis in children. J Pediatr 1989; 115:881-887
3. Adzick NS, Kim SH, Bondoc CC, et al: Management of toxic epidermal necrolysis in the pediatric burn center. Am J Dis Child 1985; 139:499-501
4. Heimbach DM, Engrav LH, Marvin JA, et al: Toxic epidermal necrolysis, a step forward in treatment. JAMA 1987; 257:2171-2173
5. Green D, Law E, Still JM: An approach to the management of toxic epidermal necrolysis in a burn center. Burns 1993; 19:411-414
6. Anderson JA: Allergic reactions to drugs and biological agents. JAMA 1992; 268:2844-2857
7. Davies NM, McLachlan AJ, Day RO, et al: Clinical pharmacokinetics and pharmacodynamics of celecoxib: A selective cyclooxygenase-2 inhibitor. Clin Pharmacokinet 2000; 38:225-242